Literature DB >> 11970976

Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.

Barbara J Vilen1, Kathy M Burke, Michelle Sleater, John C Cambier.   

Abstract

B cell tolerance can be maintained by functional inactivation, or anergy, wherein B cell Ag receptors (BCR) remain capable of binding Ag, but are unable to transduce signals. Although the molecular mechanisms underlying this unresponsiveness are unknown, some models of B cell anergy are characterized by disruption of proximal BCR signaling events, and by destabilization of the BCR complex. Receptor destabilization is manifest by a reduced ability to coimmunoprecipitate membrane Ig with the Ig-alpha/Ig-beta signal-transducing complex. To begin to explore the possibility that anergy is the consequence of receptor destabilization, we analyzed a panel of B lymphoma transfectants expressing constant amounts of signal-competent Ag receptors and varied amounts of a receptor with identical specificity, but bearing mutations that render it incapable of interacting with Ig-alpha/Ig-beta. This analysis revealed that coaggregation of signal-incompetent receptors prevented Ag-induced Ig-alpha and Syk phosphorylation, mobilization of Ca(2+), and the up-regulation of CD69 mediated by competent receptors. In contrast, Ag-induced Cbl and Erk phosphorylation were unaffected. Data indicate that coaggregation of destabilized receptors (as few as approximately 15% of total) with signal-competent receptors significantly affects the ability of competent receptors to transduce signals. Thus, BCR destabilization may underlie the Ag unresponsiveness of anergic B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970976      PMCID: PMC3726184          DOI: 10.4049/jimmunol.168.9.4344

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive.

Authors:  R J Benschop; K Aviszus; X Zhang; T Manser; J C Cambier; L J Wysocki
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

2.  The alpha/beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell antigen receptor but not for capping or for serine/threonine-kinase recruitment.

Authors:  G T Williams; C J Peaker; K J Patel; M S Neuberger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

3.  Molecular determinants of immunogenicity: the immunon model of immune response.

Authors:  H M Dintzis; R Z Dintzis; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

4.  Induction of self-tolerance in mature peripheral B lymphocytes.

Authors:  C C Goodnow; J Crosbie; H Jorgensen; R A Brink; A Basten
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

5.  Alpha-chains of IgM and IgD antigen receptor complexes are differentially N-glycosylated MB-1-related molecules.

Authors:  K S Campbell; E J Hager; J C Cambier
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

6.  Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein.

Authors:  K A Reedquist; T Fukazawa; B Druker; G Panchamoorthy; S E Shoelson; H Band
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs.

Authors:  S H Stotz; L Bolliger; F R Carbone; E Palmer
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

8.  Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.

Authors:  M P Cooke; A W Heath; K M Shokat; Y Zeng; F D Finkelman; P S Linsley; M Howard; C C Goodnow
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

9.  Physical and functional association of the cbl protooncogen product with an src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling.

Authors:  T Tezuka; H Umemori; N Fusaki; T Yagi; M Takata; T Kurosaki; T Yamamoto
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes.

Authors:  M Fournel; D Davidson; R Weil; A Veillette
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  16 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

4.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

Review 5.  The riddle of the dual expression of IgM and IgD.

Authors:  Roland Geisberger; Marinus Lamers; Gernot Achatz
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

6.  Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα mAbs.

Authors:  Marat V Khodoun; Suzanne C Morris; Wen-Hai Shao; Crystal Potter; Elizabeth Angerman; Artem Kiselev; Alexander E Yarawsky; Andrew B Herr; Katja Klausz; Anna Otte; Matthias Peipp; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2020-12-14       Impact factor: 10.793

7.  A genetic approach to inactivating chemokine receptors using a modified viral protein.

Authors:  V McNeil Coffield; Qi Jiang; Lishan Su
Journal:  Nat Biotechnol       Date:  2003-10-12       Impact factor: 54.908

8.  Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.

Authors:  Yasuyuki Kitaura; Ihn Kyung Jang; Yan Wang; Yoon-Chi Han; Tetsuya Inazu; Emily J Cadera; Mark Schlissel; Richard R Hardy; Hua Gu
Journal:  Immunity       Date:  2007-05-10       Impact factor: 31.745

9.  Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Authors:  Katja Aviszus; Megan K L Macleod; Greg A Kirchenbaum; Thiago O Detanico; Ryan A Heiser; James B St Clair; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

Review 10.  B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Authors:  John C Cambier; Stephen B Gauld; Kevin T Merrell; Barbara J Vilen
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.